Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ziegler

Showing results (271-280 of 338) with videos related to

Pageof 34
Sort By:
Cancer Biology & Therapy|October 10, 2018
Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancerMaria Tsoli, Carol Wadham, Mark Pinese, et al.
The Lancet Regional Health. Western Pacific|November 18, 2024
Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodesGabrielle M Haeusler, S Ghazaleh Dashti, Fiona James, et al.
Cancer Research|December 15, 2018
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in NeuroblastomaLivingstone Fultang, Laura D Gamble, Luciana Gneo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 19, 2025
The Super Enhancer-Driven Long Noncoding RNA PRKCQ-AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule CompoundsSujanna Mondal, Pei Y Liu, Janith Seneviratne, et al.
Cancer Cytopathology|May 27, 2021
The important role of routine cytopathology in pediatric precision oncologyJinhan Xie, Amit Kumar, M Emmy M Dolman, et al.
Cell Reports|April 14, 2021
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPGAnahid Ehteda, Sandy Simon, Laura Franshaw, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 7, 2021
Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial GroupC Ostheimer, M Mäurer, N Ebert, et al.
NPJ Genomic Medicine|February 17, 2025
Returning raw genomic data to research participants in a pediatric cancer precision medicine trialKristine Barlow-Stewart, Eliza Courtney, Mark Cowley, et al.
Oncotarget|October 21, 2016
The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugsPei Y Liu, Nicholas Sokolowski, Su T Guo, et al.
Neuro-Oncology|June 8, 2020
MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG RegistryJames L Leach, James Roebker, Austin Schafer, et al.
Pageof 34

Showing results (271-280 of 338) with videos related to

Sort By:
Pageof 34
Cancer Biology & Therapy|October 10, 2018
Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancerMaria Tsoli, Carol Wadham, Mark Pinese, et al.
The Lancet Regional Health. Western Pacific|November 18, 2024
Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodesGabrielle M Haeusler, S Ghazaleh Dashti, Fiona James, et al.
Cancer Research|December 15, 2018
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in NeuroblastomaLivingstone Fultang, Laura D Gamble, Luciana Gneo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 19, 2025
The Super Enhancer-Driven Long Noncoding RNA PRKCQ-AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule CompoundsSujanna Mondal, Pei Y Liu, Janith Seneviratne, et al.
Cancer Cytopathology|May 27, 2021
The important role of routine cytopathology in pediatric precision oncologyJinhan Xie, Amit Kumar, M Emmy M Dolman, et al.
Cell Reports|April 14, 2021
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPGAnahid Ehteda, Sandy Simon, Laura Franshaw, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 7, 2021
Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial GroupC Ostheimer, M Mäurer, N Ebert, et al.
NPJ Genomic Medicine|February 17, 2025
Returning raw genomic data to research participants in a pediatric cancer precision medicine trialKristine Barlow-Stewart, Eliza Courtney, Mark Cowley, et al.
Oncotarget|October 21, 2016
The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugsPei Y Liu, Nicholas Sokolowski, Su T Guo, et al.
Neuro-Oncology|June 8, 2020
MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG RegistryJames L Leach, James Roebker, Austin Schafer, et al.
Pageof 34